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Purpose: To evaluate mutations in the visual system homeobox gene 1 (VSX1) and superoxide dismutase 1 (SOD1) genes
with keratoconus (KTCN), direct sequencing was performed in an Iranian population.
Methods: One hundred and twelve autosomal dominant KTCN patients and fifty-two unaffected individuals from twenty-
six Iranian families, as well as one hundred healthy people as controls were enrolled. Genomic DNA was extracted from
whole blood sample. Then to study the possible linkage between KTCN and six known loci linkage analysis was performed
using 12 short tandem repeat (STR) markers. Also, the entire coding region and intron-exon boundaries of VSX1 and
SOD1 were amplified by the PCR technique in each proband. Subsequently, PCR products were subjected to direct
sequencing. Co-segregation analysis of the identified mutation was conducted in the family members. An Amplification
Refractory Mutation System PCR (ARMS-PCR) was additionally employed for detection of the identified mutation in
healthy controls.
Results: Linkage analysis of aforementioned loci did not detect evidence for linkage to KTCN. Direct PCR sequencing
revealed two single nucleotide polymorphisms (SNPs; g.1502T>G and g.9683C>T), as well as two missense mutations
that have been previously reported (R166W and H244R) in VSX1. We also found three undescribed SNPs (g.4886G>A,
g.4990C>G, and g.9061T>A) in SOD1. The R166W and H244R mutations were co-segregated in affected family members
but not in those that were unaffected. Moreover, the ARMS-PCR strategy did not detect the identified mutations in controls.
Conclusions: Our data suggest a significant association between KTCN patients and VSX1 genetic alterations (p.R166W
and p.H244R). Although our findings support VSX1 as a plausible candidate gene responsible for keratoconus, other
chromosomal loci and genes could be involved in KTCN development. Taken together, our results suggest that p.R166W
and p.H244R could have possible pathogenic influences on KTCN.
Keratoconus (KTCN; OMIM 148300) is a genetically
and clinically heterogeneous disease affecting the cornea that
causes distortion and reduced vision. KTCN is the most
common indication for corneal transplantation in developed
countries [1,2]. The estimated incidence is between 1 in 500
and 1 in 2,000 individuals in the general population and the
prevalence is estimated to be 54.5 per 100,000 [1]. It occurs
in both genders and all ethnicities [3]. Studies suggest that the
prevalence and incidence rates are higher in Asians compared
to Caucasians [4,5]. A study undertaken in the Midlands area
of the UK (UK), a prevalence of 4:1, and an incidence of 4.4:1
was reported in Asians compared to Caucasians while another
UK study conducted in Yorkshire, found that the incidence
was 7.5 times higher in Asians compared to Caucasians [6].
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Several lines of evidence support the importance of
genetic components in the pathogenesis of KTCN [6-8]. It has
been shown that the prevalence of KTCN in first-degree
relatives is significantly higher than the general population
[4,5]. Approximately 6% to 23.5% of cases had familial
transmission [9] which were inherited in either an X-linked or
autosomal recessive or dominant trait. About 90% of
pedigrees with familial KTCN exhibit an autosomal dominant
inheritance with reduced penetrance, the age of onset in
teenage years and variable clinical expression [1,4,6]. In
addition, it has been well documented that KTCN is associated
with syndromic conditions such as connective tissue disorders
(osteogenesis imperfecta, Gapo syndrome, and some subtypes
of Ehlers-Danlos syndrome) [1], pigmentary retinopathy,
Marfan’s syndrome, Noonan’s syndrome, Apert’s syndrome,
Leber congenital amaurosis, and Down syndrome [2,4,10].
KTCN appears to be a genetically heterogeneous disorder
as several chromosomal regions and genes are suggested to
be involved in the molecular etiology of KTCN. To date, many
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different chromosomal loci including 20p11-q11 (KTCN1;
OMIM 148300) [11], 16q22.3-q23.1 (KTCN2; OMIM
608932) [12], 3p14-q13 (KTCN3; OMIM 608586) [13], 2p24
(KTCN4; OMIM 609271) [14], 15q22.32–24 [15,16], and
5q14.3-q21 [17], as well as genes such as VSX1 (visual system
homeobox) and SOD1 (superoxide dismutase) have been
implicated in KTCN pathogenesis [3,4,18-23]. In addition to
genetic factors, environmental factors as well as genetic-
environmental interactions could play critical roles in KTCN
[9].
In this study, we conducted mutation detection of the
entire VSX1 and SOD1 codon sequences in 112 patients from
twenty-six Iranian families. Our results support the possible
pathogenic function of VSX1 genetic variants in probands of
two families with KTCN. To confirm the association of the
identified VSX1 variants, we performed co-segregation
analysis in affected family members and in controls. To our
knowledge, this is the first report of an association between
KTCN and VSX1 genetic alterations in Iranian patients.
METHODS
Ophthalmological examination: This study was approved by
the local Institutional Review Board (IRB) and informed
consent was obtained from all affected individuals.
Keratoconus was diagnosed based on the following criteria:
(1) distortion of the corneal surface; (2) progressive visual
acuity reduction; (3) progressive stromal thinning within
central cornea using a comprehensive ophthalmic
examination including, visual acuity measurement, corneal
imaging including topography, and Pentacam imaging  (Noor
Eye Hospital, Tehran, Iran).
Molecular genetic studies: Five milliliters of peripheral blood
was collected in test tubes containing 0.5 M EDTA. DNA was
extracted using a QIAamp DNA mini kit (Qiagen, Hilden,
Germany). Genotyping of all family members using twelve
short tandem repeat (STR) markers (Table 1) from different
chromosomal regions was conducted as previously reported
[12-14,19,24]. Briefly, PCR amplification was typically
performed in 25 μl PCR reactions, 1 U Taq DNA polymerase,
10 pmole/µl of each primer, (information on the sequences of
markers, PCR primers and data on related polymorphic
fragments was obtained from the UCSC genome browser,),
200 μM of dNTPs, 0.67 μl of 50 mM MgCl2, 60 ng DNA and
2.5 μl of 10× PCR buffer). The PCR conditions included an
initial denaturation step for 3 min at 95 °C, 30 s at 95 °C, 45
s at 64 °C with a 1 °C decrease every second cycle down to
55 °C, then 55 °C for 14 cycles, 1 min at 72 °C for extension,
and finally 10 min at 72 °C. PCR-amplified products in
genotyping were separated on 12% polyacrylamide gels and
the bands detected using silver staining as previously
described [25]. Briefly, the gel was fixed in a solution consists
of 10% acetic acid and stained with a solution containing
silver nitrate and formaldehyde for 30 min. Subsequently, the
gel was rinsed and developed in an ice-cold alkaline sodium
carbonate solution containing formaldehyde and sodium
thiosulphate.
Mutation screening was performed for the complete
coding regions of VSX1 and SOD1 using specific primers
(Table 2) under the same PCR conditions as above. PCR
products were directly sequenced (Gene, Fanavaran, Iran).
Sequence data searches were performed in non-redundant
nucleic and protein databases BLAST. Also, in this study, we
used different softwares such as Chromas, HaploPainter V.
024 Beta, easyLinkage PLUS v5.05, and Cyrillic 2.1.
Amplification refractory mutation system PCR (ARMS-PCR):
The ARMS-PCR method was applied for the screening of
identified mutations in VSX1 in unaffected and control
individuals. Primer sequences are shown in Table 2.
Mismatches were included to maximize discrimination of the
wild-type and mutant alleles. Amplifications were performed
as outlined above. All samples under investigation were
analyzed simultaneously alongside positive and negative
controls for the R166W and H244R mutations. To determine
TABLE 1. LIST OF STR MARKERS USED IN THIS STUDY.
Marker Position CM Chr
D16S2624 56051189–56051331 (bp) 87.62 (cM) 16q22.3-q23.1
D16S3090 61948845–61949107 (bp) 92.10 (cM) 16q22.3-q23.1
D3S1312 62406410–62406632 (bp) 82.24 (cM) 3p14.2
D3S3683 110636567–110636738 (bp) 127.89 (cM) 3q13.2
D5S2499 87363565–87363812 (bp) 102.62 (cM) 5q
D5S495 94814389–94814609 (bp) 108.07 (cM) 5q
D2S305 19099786–19100000 (bp) 38.87(cM) 2p24.2
D2S2373 20842807–20842972 (bp) 42.65(cM) 2p25-p22
D20S119 40357700–40357811 (bp) 61.77 (cM) 20q11.2-q13.2
D20S838 41348847–41348967 (bp) 64.88 (cM) 20q11.2-q13.1
Cyp11a1 51426178–51426904 (bp) 60.31 (cM) 15q23-q24
D15S211 57951161–57951385 (bp) 75.85 (cM) 15q24
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the genotype results, amplification products were resolved on
2% agarose gels stained with ethidium bromide.
RESULTS
Probands from 26 Iranian families were identified with
KTCN. All affected and controls were born after a normal
term pregnancy. Retinoscopy, corneal topography, and
Pentacam examinations of probands’ first-degree relatives
discriminated KTCN from normal individuals. Affected cases
were clinically examined and showed no signs and symptoms
of any syndromic indication. KTCN was excluded in normal
controls by retinoscopy, corneal topography, and Pentacam
examination.
Linkage analysis results: To investigate the association
of six known (20p11-q11, 16q22.3-q23, 3p14-q13, 2p24,
15q22.32–24, and 5q14.3-q21) genetic loci with KTCN,
genomic DNA was isolated from 112 affected 52 unaffected
family members. First, PCR primers were used to amplify
polymorphic markers (Table 1) on chromosome 20p11-q11,
16q22.3-q23, 3p14-q13, 2p24, 15q22.32–24, and 5q14.3-q21
known to be linked to KTCN. Then, PCR products were
separated by PAGE. Haplotype analysis could not define
linkage between known loci with KTCN in the studied
families (as shown in Appendix 1).
Mutation analysis of VSX1: Direct PCR sequencing using
forward and reverse primers (Table2) was conducted to
evaluate genetic alterations in the coding sequence and exon/
intron boundaries of VSX1. We found two single nucleotide
polymorphisms (SNPs) (g.1502T>G and g.9683C>T) and
two non-synonymous mutations (H244R and R166W) in
VSX1 (Figure 1 and Figure 2).
In family 1, the H244R mutation was identified in a 21-
year-old female. The proband had three affected relatives
(Figure 1A). To test the pathologic function of this genetic
mutation, co-segregation of H244R (Figure 1B) in other
affected family members were performed using PCR
sequencing. We also screened the H244 R VSX1 mutation in
TABLE 2. LIST OF VSX1 AND SOD1 PRIMERS AND PREDICTED PCR PRODUCT SIZES (BP) USED IN THIS STUDY.
Primer Sequence (5'→3') PCR product size (bp) Primer location
VSX1 primer sequences
V1F 5′-GCAGCCCAATCCTATAAAGC-3′ 687 1–20
V1R 5′-GATTACCGGACGTGGAGA-3′ 469–486
V2F 5′-AAGTCCTCTTCTTCTTTCTGTGCCATC-3′ 800 2610–2637
V2R 5′-AAGGGACTGCTGATTGGCTCACTG-3′ 3386- 3409
V3F 5′-ATCATGCTCGGGAGAGAAGA-3′ 487 4178–4197
V3R 5′-AAAATGAGGCAACCATCCAG-3′ 4639–4660
V4F 5′-CCAATGCCAATCACTGTGTC3′ 306 5366–5385
V4R 5′-CCCAGAGTCCTGCCAACTTA-3′ 5652–5672
V5F 5′-AGGAAGTGAAGATAAGTTGGCAG-3′ 470 5640–5662
V5R 5′-TAAAGTGCCATTAAGGAACCG-3′ 6110–6090
V6F 5′-AACGGTTCCTTAATGGCACTT-3′ 301 6088–6109
V6R 5′-TTGAAATATCCAAGGCCAAGTT-3′ 6367–6388
V7F 5′-ATCATAGTGAAGACTCCATACAGACA-3′ 424 6312–6337
V7R 5′-AGCCCTCACAATGAGCAGTT-3′ 6964–6984
V8F 5′-GAGGCAGCATCTCAGGACTT-3′ 534 9834–9854
V8R 5′-AGGTGTGAGGTACAGGTCCAA-3′ 9321–9340
V9F 5′-GCTCAGGTAGCATTGTTCTGC-3′ 610 10272–10292
V9R 5′-TGATGGAAGGAGAGGAGAAGG-3′ 10861–10881
ARMS primers
VSM 5′-AGTCTGGCAGCGAGATGTAGC-3′ 236 4392–4411
VSWT 5′-ACTGCATCCCGCTGCCAGACT-3′ 43911–4411
VSF 5′-GGATCATGCTCGGGAGAGAAGA-3′ 4176–4197
SOD1 primer sequences
S1F 5′-CTCCACATTTCGGGGTTCT-3′ 450 4850–4868
S1R 5′-ACCCGCTCCTAGCAAAGGT-3′ 5281–5292
S2F 5′-CCATCTCCCTTTTGAGGACA-3′ 426 8965–8985
S2R 5′-CGACAGAGCAAGACCCTTTC-3′ 9371–9390
S3F 5′-TGATGCAGGTCAGCACTTTC-3′ 344 11717–11736
S3R 5′-AAAAGCATTCCAGCATTTGG-3′ 12041–12060
S4F 5′-CCATCTTTCTTCCCAGAGCA-3′ 386 12810–12840
S4R 5′-GAAACCGCGACTAACAATCAA-3 12454–12473
S5F 5′-TTTGGGTATTGTTGGGAGGA-3′ 675 13780–13799
S5R 5′-TCTGTTCCACTGAAGCTGTTT-3′ 14334–14355
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100 controls by ARMS-PCR (Figure 1C). Direct sequencing
and ARMS-PCR results confirmed that only affected patients
carried p.H244R in the heterozygous state, while Figure 1B
(right) indicates the wild-type (WT) variant of VSX1 gene at
codon position 244.
Figure 1. Pedigree analysis and molecular study of Family 1. A: DNA sequencing revealed heterozygous missense mutation in the codon 244
VSX1 in which A→G (arrow indicates the position of nucleotide substitution). B: Amplification refractory mutation system (ARMS) for
H244R VSX1 genotyping showing the co-segregation of the H244R VSX1 mutation among family members including two KTCN patients
(III:1 and II:6) as well as in two individuals without KTCN clinical features (III:2 and II:5). PCR products of the internal control primer pair
(383 bp), PCR product of the wild-type (WT) and mutant primer pairs (236 bp) are indicated. M, 50-bp ladder is present. C: The pedigree of
Family 1 show four affected patients (arrow indicates the proband) and segregation of p.H244R through the family. Each individual was
reported by age (in years), genotype and topography images. Filled symbols represent KTCN patient and open symbols reveal individuals
without clinical KTCN.
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In family 2, the R166W mutation was detected in an 18-
year-old male (Figure 2A). Figure 2B indicates R166W in II-1
(proband) and his father (I-1). Although the proband and his
father presented a variable expressivity of KTCN, the R166W
co-segregated among KTCN, but not in unaffected his mother.
Mutation analysis of SOD1: We additionally evaluated a
possible association of KTCN with SOD1 genetic alterations.
The full-length SOD1 coding sequence was screened by direct
PCR sequencing. In spite of the fact that three novel SNPs (g.
4886G>A, g.4990C>G, and g.9061T>A) were identified in
non-coding sequences, however, sequencing the coding
region did not reveal a sequence variant segregating with
disease in any of the families described. The SNPs did not
seem to influence the activity of SOD1 protein.
DISCUSSION
Various genome-wide linkage analyses and mutation
detection studies have reported that six loci and two genes
(SOD1 and VSX1) are thought to be associated with KTCN in
different ethnic groups [6]. In this study, we performed
linkage analysis for six known chromosomal loci as well as a
Figure 2. Pedigree analysis and molecular study of Family 2. A: DNA sequencing chromatogram from heterozygous mutant of proband (II:
1) showed missense mutation in codon 166 in which Arg was replaced by Trp (R166W C>T; arrow indicates the position of nucleotide
substitution). B: The Pedigree of Family 2 indicates two affected patients (arrow indicates the proband) as well as the segregation of p.R166W
in the family. The each family's member was presented by age (in years), genotype and topography images. Filled symbols show KTCN
patient while open symbols represent persons without clinical KTCN.
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mutation detection screen in VSX1 and SOD1 in 112 affected,
52 unaffected family members and 100 normal individuals as
controls in a group of Iranian patients with keratoconus. All
studied families displayed an autosomal dominant pattern of
KTCN with variable expressivity. According to literature
KTCN is a complex disorder with multiplfactorial etiology. It
has been well documented that genetic and environmental
factors are associated with this disease. Different studies have
shown that about 90 percent of pedigrees with familial KTCN
display an autosomal dominant inheritance with incomplete
penetrance [11,16]. Our pedigree analysis showed a reduced
penetrance (about 58%) among Iranian families with KTCN.
Genotyping results using linkage analysis failed to detect
any significant correlations between known loci and KTCN.
Direct PCR sequencing did not show important genetic
changes in SOD1, although three novel SNPs were found in
the probands of three families with KTCN.
For VSX1, we observed two previously undescribed SNPs
(g.1502T>G and g.9683C>T) in addition to two missense
mutations that had been previously reported (R166W and
H244R) [11].
The VSX1 homeobox gene encodes a homeodomain
transcription factor that may regulate expression of the cone
opsin genes early in normal development [26].Despite the fact
that VSX1 remains the only major genetic element to be
identified in KTCN pathogenesis, there has been debate in the
literature in regard to its pathobiological function in KTCN.
So far, several VSX1 protein coding changes (p.L17P,
p.D144E, p.L159M, p.G160D, p.R166W, p.H244R, and
p.P247R) have been reported as being potentially pathogenic
in KTCN [3,27,28]. Valleix et al. [29] reported that H244R
VSX1 is associated with selective cone ON bipolar cell
dysfunction and macular degeneration in a posterior
polymorphous corneal dystrophy (PPCD) family [29].
However, different studies in several ethnic groups [3,30,31]
did not detect any mutations in VSX1 [21,32,33].
To evaluate the possible function of p.H244R genetic
alteration we undertook co-segregation analysis and mutation
detection in the subject families and 100 unaffected
individuals, respectively. The mutation was not observed in
100 unaffected people who were examined by corneal
topography followed by Pentacam evaluation. Therefore, for
first time, our results support the notion that p.H244R could
represent a pathogenic change in KTCN, although it has been
previously identified [11]. Héon et al. [11] showed that the
VSX1 mutation p.H244R co-segregated with the disease in
two family members. However, they also observed this
genetic change in two controls (n=277). For that reason, they
suggested that this change may or may not be disease-causing
[11]. These results could be due to several factors, such as the
mode of inheritance, gene-gene interaction, gene-
environment interaction, and genetic background. About 90%
of pedigrees with familial KTCN are predominately
transmitted in an autosomal-dominant fashion with an
incomplete penetrance and variable expressivity [9]. A
comparison of the findings obtained in our study and from
other studies raises a critical question: what could be the
biologic significance of the observation of VSX1 H244R
alteration in KTCN? With respect to this event, there are
several possibilities that may account for the presence of the
VSX1 H244R change observed in our family including:
1. random appearance in the affected members
without any biologic significance,
2. the H244R mutation may not directly cause the
disease but its pathogenic functions could be due to
gene-gene interactions, gene-environment
interactions, or genetic background, or
3. the presence of this change in the unaffected
individual suggests that this could be a causative
mutation with incomplete penetrance.
Our results suggest that the H244R VSX1 change may be
a pathogenic variant with incomplete penetrance.
The R166W VSX1 mutation was also initially found in an
isolated case of keratoconus with visual impairment for whom
a corneal graft was required in adulthood [11]. We observed
this mutation in the proband of a family with two affected
patients with KTCN. Our results showed that R166W was co-
segregated in two affected family members, but not in
unaffected individuals and controls. The R166W alters the
highly conserved third amino acid of the DNA binding
homeodomain (HD). Dorval et al. [34] suggested that this
mutation causes keratoconus in humans by impairing VSX1
DNA binding [34].
Three SNPs were identified in non-coding sequences of
the SOD1 gene. This gene is located on chromosome 21 and
functions to destroy free superoxide radicals in the body
[22]. The association of SOD1 mutation with KTCN was
originally reported by Udar et al. [22]. SOD1 mutations were
screened in 15 unrelated individuals, each with a family
history of KTCN. Results from this study determined an
IVS2+50del7 change within intron 2 in two families. Also,
they observed that this 7-base deletion segregated with the
KTCN subjects in a studied pedigree [22]. However, an
independent study failed to define any association between
SOD1 mutations and KTCN [34]. Stabuc-Silih and colleagues
[33] studied the association of KTCN with VSX1 and SOD1
gene mutations in 113 Slovenian patients with sporadic and
familial KTCN by direct sequencing. They found no causative
disease mutation in the SOD1 gene but a significant
association was detected between a VSX1 polymorphism
(627+23G>A) and KTCN [33]. Our findings are in agreement
with published data suggesting that other genetic and non-
genetic factors are involved the pathogenesis of KTCN.
We conclude that the R166W and H244R VSX1 variants
might play critical roles in the pathogenesis of KTCN. To test
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the potential pathogenic relevance of these variants we
performed co-segregation analysis in all affected and
unaffected family members. To rule out the incomplete
penetrance of autosomal dominant KTCN in unaffected
family members, we conducted precise clinical examinations
of unaffected individuals; a crucial step in an association study
involving a molecular genetic analysis of an autosomal
dominant disorder. An accurate diagnosis and exclusion of
keratoconus in patients and controls (n=100), respectively,
was made using corneal topography and Pentacam evaluation.
Our findings suggest that the R166W and H2446R mutations
might be involved in KTCN pathogenesis.
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Appendix 1. Twenty six pedigrees of KTCN.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Molecular Vision 2011; 17:3128-3136 <http://www.molvis.org/molvis/v17/a337> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 27 November 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
3136
